Picard Medical, Inc. (PMI)
Picard Medical will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Company Description
Picard Medical owns 100% of the membership interests of SynCardia Systems.
SynCardia is a medical technology company that manufactures and sells the only U.S. Food and Drug Administration, and Health Canada approved implantable total artificial heart (the “SynCardia TAH”).
To date, over 2,100 SynCardia TAHs have been implanted in patients in 27 countries and the SynCardia TAH is an established bridge to heart transplantation for patients with biventricular failure in the U.S., and around the world.
Picard Medical, Inc.
| Country | United States |
| Founded | 1981 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 75 |
| CEO | Patrick NJ Schnegelsberg |
Contact Details
Address: 1992 E Silverlake Tucson, AZ 85713 United States | |
| Phone | (520) 545-1234 |
| Website | syncardia.com |
Stock Details
| Ticker Symbol | PMI |
| Exchange | NYSEAMERICAN |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002030617 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Patrick NJ Schnegelsberg | Chief Executive Officer and Director |
| Bernard Skaggs | Chief Financial Officer |
| Matt Schuster | Chief Operating Officer |
| Richard Fang | Director |
| Daniel Teo | Director |
| Chris Hsieh | Director |
| Richard G. Smith | Scientific Advisor, SynCardia |
| Frank Tinker | Chief Technology Officer, SynCardia |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 1, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Jan 24, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Dec 26, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Nov 12, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Aug 23, 2024 | DRS | [Cover] Draft Registration Statement |